Furthermore, given we found that the inhibition of a single protein, caspase-8, is able to reproduce the same effects in human monocytes, we hypothesize that the treatment of SIRS with caspase-8 inhibitors may provide positive results. Here, CASP8 is linked to systemic inflammatory response syndrome.